Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision.

PHASE2CompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Hodgkin Lymphoma
Interventions
OTHER

PET/CT post 2 cycles of chemotherapy

sintigraphy with PET/CT following 2 cycles of chemotherapy on day 12-14 following chemotherapy

Trial Locations (1)

30063

RAMBAM health care campus, Haifa

All Listed Sponsors
collaborator

Hadassah Medical Organization

OTHER

collaborator

Rabin Medical Center

OTHER

lead

Rambam Health Care Campus

OTHER

NCT00392314 - Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision. | Biotech Hunter | Biotech Hunter